TERM ID="NYU_TERM_1" STRING="AVADO" FREQUENCY=3 START=1670 END=1675 LEMMA="AVADO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_2" STRING="AVADO" FREQUENCY=3 START=1878 END=1883 LEMMA="AVADO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="AVADO" FREQUENCY=3 START=2026 END=2031 LEMMA="AVADO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="Avastin" FREQUENCY=2 START=213 END=220 LEMMA="AVASTIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_5" STRING="Avastin" FREQUENCY=2 START=1677 END=1684 LEMMA="AVASTIN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_6" STRING="BEV" FREQUENCY=9 START=2813 END=2816 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_7" STRING="BEV" FREQUENCY=9 START=2856 END=2859 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_8" STRING="BEV" FREQUENCY=9 START=2879 END=2882 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_9" STRING="BEV" FREQUENCY=9 START=3015 END=3018 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_10" STRING="BEV" FREQUENCY=9 START=3237 END=3240 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_11" STRING="BEV" FREQUENCY=9 START=3274 END=3277 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_12" STRING="BEV" FREQUENCY=9 START=3403 END=3406 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_13" STRING="BEV" FREQUENCY=9 START=3496 END=3499 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_14" STRING="BEV" FREQUENCY=9 START=3698 END=3701 LEMMA="BEV" LEMMA_FREQUENCY=9
TERM ID="NYU_TERM_15" STRING="Bevacizumab" FREQUENCY=1 START=0 END=11 LEMMA="BEVACIZUMAB" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_16" STRING="DOC" FREQUENCY=4 START=2542 END=2545 LEMMA="DOC" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_17" STRING="DOC" FREQUENCY=4 START=2870 END=2873 LEMMA="DOC" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_18" STRING="DOC" FREQUENCY=4 START=3097 END=3100 LEMMA="DOC" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_19" STRING="DOC" FREQUENCY=4 START=3409 END=3412 LEMMA="DOC" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_20" STRING="Docetaxel" FREQUENCY=1 START=1689 END=1698 LEMMA="DOCETAXEL" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_21" STRING="E2100 trial" FREQUENCY=2 START=2284 END=2295 LEMMA="E2100 TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_22" STRING="E2100 trial" FREQUENCY=2 START=2842 END=2853 LEMMA="E2100 TRIAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_23" STRING="FACT-B" FREQUENCY=1 START=1184 END=1190 LEMMA="FUNCTIONAL ASSESSMENT OF CANCER THERAPY FOR BREAST " LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="HER2-negative metastatic breast cancer" FREQUENCY=1 START=73 END=111 LEMMA="HER2-NEGATIVE METASTATIC BREAST CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="ICERs" FREQUENCY=1 START=3004 END=3009 LEMMA="INCREMENTAL COST EFFECTIVENESS RATIOS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="Median" FREQUENCY=1 START=798 END=804 LEMMA="MEDIAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="NHS" FREQUENCY=4 START=2627 END=2630 LEMMA="NHS" LEMMA_FREQUENCY=4 HEAD_TERM="NHS" HEAD_LEMMA="NHS" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_28" STRING="NHS" FREQUENCY=4 START=2913 END=2916 LEMMA="NHS" LEMMA_FREQUENCY=4 HEAD_TERM="NHS" HEAD_LEMMA="NHS" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_29" STRING="NHS" FREQUENCY=4 START=2913 END=2916 LEMMA="NHS" LEMMA_FREQUENCY=4 HEAD_TERM="NHS" HEAD_LEMMA="NHS" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_30" STRING="NHS" FREQUENCY=4 START=3146 END=3149 LEMMA="NHS" LEMMA_FREQUENCY=4 HEAD_TERM="NHS" HEAD_LEMMA="NHS" TERM_PATTERN_TYPE="chemical"
TERM ID="NYU_TERM_31" STRING="NHS list prices" FREQUENCY=1 START=2913 END=2928 LEMMA="LIST PRICE NHS" LEMMA_FREQUENCY=1 HEAD_TERM="list prices" HEAD_LEMMA="LIST PRICE"
TERM ID="NYU_TERM_32" STRING="PAC q.w" FREQUENCY=1 START=2450 END=2457 LEMMA="PAC Q.W" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="PFS" FREQUENCY=2 START=742 END=745 LEMMA="PROGRESSION FREE SURVIVAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="PFS" FREQUENCY=2 START=1873 END=1876 LEMMA="PROGRESSION FREE SURVIVAL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_35" STRING="Pairwise comparisons" FREQUENCY=1 START=2774 END=2794 LEMMA="PAIRWISE COMPARISON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="QALY" FREQUENCY=2 START=3067 END=3071 LEMMA="QALY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_37" STRING="QALY" FREQUENCY=2 START=3338 END=3342 LEMMA="QALY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_38" STRING="RCT" FREQUENCY=2 START=427 END=430 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_39" STRING="RCT" FREQUENCY=2 START=1665 END=1668 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_40" STRING="Supply Agency prices" FREQUENCY=1 START=3165 END=3185 LEMMA="SUPPLY AGENCY PRICE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="UK NHS" FREQUENCY=1 START=2624 END=2630 LEMMA="UK NH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="UK NHS clinical practice" FREQUENCY=1 START=2624 END=2648 LEMMA="CLINICAL PRACTICE UK NH" LEMMA_FREQUENCY=1 HEAD_TERM="clinical practice" HEAD_LEMMA="CLINICAL PRACTICE"
TERM ID="NYU_TERM_43" STRING="adding bevacizumab" FREQUENCY=2 START=1923 END=1941 LEMMA="ADDING BEVACIZUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_44" STRING="adding bevacizumab" FREQUENCY=2 START=1978 END=1996 LEMMA="ADDING BEVACIZUMAB" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_45" STRING="addition" FREQUENCY=4 START=459 END=467 LEMMA="ADDITION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_46" STRING="addition" FREQUENCY=4 START=755 END=763 LEMMA="ADDITION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_47" STRING="addition" FREQUENCY=4 START=1052 END=1060 LEMMA="ADDITION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_48" STRING="addition" FREQUENCY=4 START=1725 END=1733 LEMMA="ADDITION" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_49" STRING="addition of bevacizumab" FREQUENCY=1 START=755 END=778 LEMMA="BEVACIZUMAB ADDITION" LEMMA_FREQUENCY=1 HEAD_TERM="addition" HEAD_LEMMA="ADDITION"
TERM ID="NYU_TERM_50" STRING="assessed BEV" FREQUENCY=1 START=2307 END=2319 LEMMA="ASSESSED BEV" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="baseline characteristics" FREQUENCY=1 START=2243 END=2267 LEMMA="BASELINE CHARACTERISTIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="bevacizumab" FREQUENCY=3 START=200 END=211 LEMMA="BEVACIZUMAB" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_53" STRING="bevacizumab" FREQUENCY=3 START=767 END=778 LEMMA="BEVACIZUMAB" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_54" STRING="bevacizumab" FREQUENCY=3 START=2328 END=2339 LEMMA="BEVACIZUMAB" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_55" STRING="cancer therapy" FREQUENCY=1 START=1217 END=1231 LEMMA="CANCER THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="clinical effectiveness data" FREQUENCY=1 START=331 END=358 LEMMA="CLINICAL EFFECTIVENESS DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="clinical practice" FREQUENCY=1 START=2631 END=2648 LEMMA="CLINICAL PRACTICE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="combination therapy" FREQUENCY=1 START=2085 END=2104 LEMMA="COMBINATION THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="controlled trial" FREQUENCY=1 START=409 END=425 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="de novo economic model" FREQUENCY=1 START=2181 END=2203 LEMMA="DE NOVO ECONOMIC MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="docetaxel" FREQUENCY=3 START=1752 END=1761 LEMMA="DOCETAXEL" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_62" STRING="docetaxel" FREQUENCY=3 START=2112 END=2121 LEMMA="DOCETAXEL" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_63" STRING="docetaxel" FREQUENCY=3 START=2548 END=2557 LEMMA="DOCETAXEL" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_64" STRING="epidermal growth factor receptor" FREQUENCY=1 START=534 END=566 LEMMA="EPIDERMAL GROWTH FACTOR RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_65" STRING="evidence review group" FREQUENCY=1 START=149 END=170 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="exchangeability" FREQUENCY=1 START=1547 END=1562 LEMMA="EXCHANGEABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_67" STRING="first-line treatment" FREQUENCY=1 START=49 END=69 LEMMA="FIRST-LINE TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_68" STRING="functional assessment" FREQUENCY=1 START=1192 END=1213 LEMMA="FUNCTIONAL ASSESSMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_69" STRING="functional assessment of cancer therapy" FREQUENCY=1 START=1192 END=1231 LEMMA="CANCER THERAPY FUNCTIONAL ASSESSMENT" LEMMA_FREQUENCY=1 HEAD_TERM="functional assessment" HEAD_LEMMA="FUNCTIONAL ASSESSMENT"
TERM ID="NYU_TERM_70" STRING="gemcitabine" FREQUENCY=1 START=2685 END=2696 LEMMA="GEMCITABINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="incremental cost-effectiveness ratios" FREQUENCY=2 START=2965 END=3002 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_72" STRING="incremental cost-effectiveness ratios" FREQUENCY=2 START=2965 END=3002 LEMMA="INCREMENTAL COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_73" STRING="list prices" FREQUENCY=1 START=2917 END=2928 LEMMA="LIST PRICE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="mBC" FREQUENCY=2 START=316 END=319 LEMMA="METASTATIC BREAST CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_75" STRING="mBC" FREQUENCY=2 START=578 END=581 LEMMA="METASTATIC BREAST CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_76" STRING="manufacturer" FREQUENCY=5 START=1021 END=1033 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_77" STRING="manufacturer" FREQUENCY=5 START=1419 END=1431 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_78" STRING="manufacturer" FREQUENCY=5 START=1783 END=1796 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_79" STRING="manufacturer" FREQUENCY=5 START=2156 END=2168 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_80" STRING="manufacturer" FREQUENCY=5 START=2933 END=2946 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_81" STRING="median progression-free survival" FREQUENCY=1 START=708 END=740 LEMMA="MEDIAN PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_82" STRING="metastatic breast cancer" FREQUENCY=2 START=290 END=314 LEMMA="METASTATIC BREAST CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_83" STRING="metastatic breast cancer" FREQUENCY=2 START=290 END=314 LEMMA="METASTATIC BREAST CANCER" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_84" STRING="methodological limitations" FREQUENCY=1 START=1484 END=1510 LEMMA="METHODOLOGICAL LIMITATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_85" STRING="mg" FREQUENCY=5 START=2397 END=2399 LEMMA="MG" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_86" STRING="mg" FREQUENCY=5 START=2489 END=2491 LEMMA="MG" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_87" STRING="mg" FREQUENCY=5 START=2575 END=2577 LEMMA="MG" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_88" STRING="mg" FREQUENCY=5 START=2702 END=2704 LEMMA="MG" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_89" STRING="mg" FREQUENCY=5 START=2744 END=2746 LEMMA="MG" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_90" STRING="mg/kg" FREQUENCY=1 START=2343 END=2348 LEMMA="MG/KG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_91" STRING="model assumptions" FREQUENCY=1 START=3655 END=3672 LEMMA="MODEL ASSUMPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_92" STRING="monotherapy" FREQUENCY=2 START=2473 END=2484 LEMMA="MONOTHERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_93" STRING="monotherapy" FREQUENCY=2 START=2559 END=2570 LEMMA="MONOTHERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_94" STRING="non-significant differences" FREQUENCY=1 START=1367 END=1394 LEMMA="NON-SIGNIFICANT DIFFERENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_95" STRING="open-label" FREQUENCY=1 START=387 END=397 LEMMA="OPEN-LABEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_96" STRING="paclitaxel" FREQUENCY=5 START=500 END=510 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_97" STRING="paclitaxel" FREQUENCY=5 START=2005 END=2015 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_98" STRING="paclitaxel" FREQUENCY=5 START=2383 END=2393 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_99" STRING="paclitaxel" FREQUENCY=5 START=2461 END=2471 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_100" STRING="paclitaxel" FREQUENCY=5 START=2729 END=2739 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_101" STRING="paclitaxel q.w" FREQUENCY=1 START=1079 END=1093 LEMMA="PACLITAXEL Q.W" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_102" STRING="progression-free survival" FREQUENCY=1 START=715 END=740 LEMMA="PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_103" STRING="q.w" FREQUENCY=1 START=2000 END=2003 LEMMA="Q.W" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_104" STRING="randomised controlled trial" FREQUENCY=1 START=398 END=425 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_105" STRING="response rate" FREQUENCY=1 START=1855 END=1868 LEMMA="RESPONSE RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_106" STRING="taxane" FREQUENCY=2 START=34 END=40 LEMMA="TAXANE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_107" STRING="taxane" FREQUENCY=2 START=252 END=258 LEMMA="TAXANE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_108" STRING="taxane for the first-line treatment" FREQUENCY=1 START=34 END=69 LEMMA="FIRST-LINE TREATMENT TAXANE" LEMMA_FREQUENCY=1 HEAD_TERM="taxane" HEAD_LEMMA="TAXANE"
TERM ID="NYU_TERM_109" STRING="taxane for the first-line treatment of HER2-negative metastatic breast cancer" FREQUENCY=1 START=34 END=111 LEMMA="HER2-NEGATIVE METASTATIC BREAST CANCER FIRST-LINE TREATMENT TAXANE" LEMMA_FREQUENCY=1 HEAD_TERM="taxane for the first-line treatment" HEAD_LEMMA="FIRST-LINE TREATMENT TAXANE"
TERM ID="NYU_TERM_110" STRING="treatment arms" FREQUENCY=1 START=942 END=956 LEMMA="TREATMENT ARM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_111" STRING="week" FREQUENCY=2 START=2436 END=2440 LEMMA="WEEK" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_112" STRING="week" FREQUENCY=2 START=2528 END=2532 LEMMA="WEEK" LEMMA_FREQUENCY=2
